ArticleMedComm2025

PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study.

Riqing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.